Skip to main content
Top
Published in: Clinical Rheumatology 11/2014

01-11-2014 | Original Article

Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis

Authors: Young Ho Lee, Sang-Cheol Bae, Gwan Gyu Song

Published in: Clinical Rheumatology | Issue 11/2014

Login to get access

Abstract

The aim of this study was to analyze published results for an association between coffee or tea intake and the development of rheumatoid arthritis (RA). We investigated the evidence for a relationship between coffee or tea consumption and the development of RA by performing a meta-analysis of the published results. Five studies (three cohort and two case–control studies) including 134,901 participants (1,279 cases of RA and 133,622 noncases) were considered in the meta-analysis. Meta-analysis of the cohort studies revealed a trend of an association between total coffee intake and RA incidence (relative risk [RR] of the highest versus the lowest group = 4.148, 95 % confidence interval [CI] = 0.792–21.73, p = 0.092). Meta-analysis of case–control studies showed a significant association between total coffee intake and RA incidence (RR = 1.201, 95 % CI = 1.058–1.361, p = 0.005). Combining the data of the cohort and case–control studies showed a significant association between total coffee intake and RA incidence (RR = 2.426, 95 % CI = 1.060–5.554, p = 0.036). Meta-analysis stratified by seropositivity indicated a significant association between coffee consumption and seropositive RA risk (RR = 1.329, 95 % CI = 1.162–1.522, p = 3.5 × 10−5), but not seronegative RA risk (RR = 1.093, 95 % CI = 0.884–1.350, p = 0.411). No association was found between tea intake and RA incidence (RR = 0.880, 95 % CI = 0.624–1.239, p = 0.463). This meta-analysis of 134,901 participants (most of the participants were controls) suggests that high coffee consumption is associated with an elevated risk of RA development. The association between coffee and RA was found in seropositive RA, but not in seronegative RA.
Literature
1.
go back to reference Harris ED Jr (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322(18):1277–1289PubMedCrossRef Harris ED Jr (1990) Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med 322(18):1277–1289PubMedCrossRef
2.
go back to reference Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45(2):166–170CrossRef Choi SJ, Rho YH, Ji JD, Song GG, Lee YH (2006) Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 45(2):166–170CrossRef
3.
go back to reference Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L et al (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case–control study, using incident cases. Ann Rheum Dis 62(9):835–841PubMedCentralPubMedCrossRef Stolt P, Bengtsson C, Nordmark B, Lindblad S, Lundberg I, Klareskog L et al (2003) Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case–control study, using incident cases. Ann Rheum Dis 62(9):835–841PubMedCentralPubMedCrossRef
4.
go back to reference Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67(4):466–470PubMedCrossRef Michou L, Teixeira VH, Pierlot C, Lasbleiz S, Bardin T, Dieude P et al (2008) Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis. Ann Rheum Dis 67(4):466–470PubMedCrossRef
6.
go back to reference Karlson EW, Mandl LA, Aweh GN, Grodstein F (2003) Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 48(11):3055–3060PubMedCrossRef Karlson EW, Mandl LA, Aweh GN, Grodstein F (2003) Coffee consumption and risk of rheumatoid arthritis. Arthritis Rheum 48(11):3055–3060PubMedCrossRef
7.
go back to reference Mikuls TR, Cerhan JR, Criswell LA, Merlino L, Mudano AS, Burma M et al (2002) Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 46(1):83–91PubMedCrossRef Mikuls TR, Cerhan JR, Criswell LA, Merlino L, Mudano AS, Burma M et al (2002) Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: results from the Iowa Women’s Health Study. Arthritis Rheum 46(1):83–91PubMedCrossRef
8.
go back to reference Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J et al (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 8(4):R133PubMedCentralPubMedCrossRef Pedersen M, Jacobsen S, Klarlund M, Pedersen BV, Wiik A, Wohlfahrt J et al (2006) Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides. Arthritis Res Ther 8(4):R133PubMedCentralPubMedCrossRef
9.
go back to reference Heliovaara M, Aho K, Knekt P, Impivaara O, Reunanen A, Aromaa A (2000) Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 59(8):631–635PubMedCentralPubMedCrossRef Heliovaara M, Aho K, Knekt P, Impivaara O, Reunanen A, Aromaa A (2000) Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis 59(8):631–635PubMedCentralPubMedCrossRef
10.
go back to reference Pattison DJ, Symmons DP, Young A (2004) Does diet have a role in the aetiology of rheumatoid arthritis? Proc Nutr Soc 63(1):137–143PubMedCrossRef Pattison DJ, Symmons DP, Young A (2004) Does diet have a role in the aetiology of rheumatoid arthritis? Proc Nutr Soc 63(1):137–143PubMedCrossRef
11.
go back to reference Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 46(1):49–56CrossRef Lee YH, Rho YH, Choi SJ, Ji JD, Song GG, Nath SK et al (2007) The PTPN22 C1858T functional polymorphism and autoimmune diseases—a meta-analysis. Rheumatology (Oxford) 46(1):49–56CrossRef
12.
go back to reference Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833PubMedCrossRef Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2007) PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int 27(9):827–833PubMedCrossRef
13.
go back to reference Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38(6):3643–3651PubMedCrossRef Lee YH, Bae SC, Choi SJ, Ji JD, Song GG (2011) Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep 38(6):3643–3651PubMedCrossRef
14.
go back to reference Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Gliksman M (1997) Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis. Clin Ther 19(4):656–674PubMedCrossRef Davey P, Grainger D, MacMillan J, Rajan N, Aristides M, Gliksman M (1997) Clinical outcomes with insulin lispro compared with human regular insulin: a meta-analysis. Clin Ther 19(4):656–674PubMedCrossRef
15.
16.
go back to reference Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12PubMedCrossRef Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1–12PubMedCrossRef
17.
go back to reference Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21(11):1539–1558PubMedCrossRef
19.
go back to reference Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef
20.
go back to reference Pattison DJ, Symmons DP, Lunt M, Welch A, Luben R, Bingham SA et al (2004) Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 50(12):3804–3812PubMedCrossRef Pattison DJ, Symmons DP, Lunt M, Welch A, Luben R, Bingham SA et al (2004) Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption. Arthritis Rheum 50(12):3804–3812PubMedCrossRef
21.
go back to reference Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A et al (2007) Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case–control study in Denmark. Arthritis Rheum 56(5):1446–1453PubMedCrossRef Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A et al (2007) Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case–control study in Denmark. Arthritis Rheum 56(5):1446–1453PubMedCrossRef
22.
go back to reference Pedersen M, Stripp C, Klarlund M, Olsen SF, Tjonneland AM, Frisch M (2005) Diet and risk of rheumatoid arthritis in a prospective cohort. J Rheumatol 32(7):1249–1252PubMed Pedersen M, Stripp C, Klarlund M, Olsen SF, Tjonneland AM, Frisch M (2005) Diet and risk of rheumatoid arthritis in a prospective cohort. J Rheumatol 32(7):1249–1252PubMed
23.
go back to reference Lahiri M, Morgan C, Symmons DP, Bruce IN (2012) Modifiable risk factors for RA: prevention, better than cure? Rheumatology (Oxford) 51(3):499–512CrossRef Lahiri M, Morgan C, Symmons DP, Bruce IN (2012) Modifiable risk factors for RA: prevention, better than cure? Rheumatology (Oxford) 51(3):499–512CrossRef
24.
go back to reference Jiang X, Zhang D, Jiang W (2014) Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53(1):25–38PubMedCrossRef Jiang X, Zhang D, Jiang W (2014) Coffee and caffeine intake and incidence of type 2 diabetes mellitus: a meta-analysis of prospective studies. Eur J Nutr 53(1):25–38PubMedCrossRef
25.
go back to reference Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C (2013) Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 11(11):1413–1421, e1PubMedCrossRef Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C (2013) Coffee reduces risk for hepatocellular carcinoma: an updated meta-analysis. Clin Gastroenterol Hepatol 11(11):1413–1421, e1PubMedCrossRef
26.
go back to reference Li XJ, Ren ZJ, Qin JW, Zhao JH, Tang JH, Ji MH et al (2013) Coffee consumption and risk of breast cancer: an up-to-date meta-analysis. PLoS One 8(1):e52681PubMedCentralPubMedCrossRef Li XJ, Ren ZJ, Qin JW, Zhao JH, Tang JH, Ji MH et al (2013) Coffee consumption and risk of breast cancer: an up-to-date meta-analysis. PLoS One 8(1):e52681PubMedCentralPubMedCrossRef
27.
go back to reference Ito K, Nakazato T, Miyakawa Y, Yamato K, Ikeda Y, Kizaki M (2003) Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J Cell Physiol 196(2):276–283PubMedCrossRef Ito K, Nakazato T, Miyakawa Y, Yamato K, Ikeda Y, Kizaki M (2003) Caffeine induces G2/M arrest and apoptosis via a novel p53-dependent pathway in NB4 promyelocytic leukemia cells. J Cell Physiol 196(2):276–283PubMedCrossRef
28.
go back to reference Cheng B, Liu X, Gong H, Huang L, Chen H, Zhang X et al (2011) Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus. J Agric Food Chem 59(24):13147–13155PubMedCrossRef Cheng B, Liu X, Gong H, Huang L, Chen H, Zhang X et al (2011) Coffee components inhibit amyloid formation of human islet amyloid polypeptide in vitro: possible link between coffee consumption and diabetes mellitus. J Agric Food Chem 59(24):13147–13155PubMedCrossRef
29.
go back to reference McCandless LC (2012) Meta-analysis of observational studies with unmeasured confounders. Int J Biostat 8(2) McCandless LC (2012) Meta-analysis of observational studies with unmeasured confounders. Int J Biostat 8(2)
31.
go back to reference Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C et al (2008) Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 23(4):487–496PubMedCentralPubMed Chen D, Milacic V, Chen MS, Wan SB, Lam WH, Huo C et al (2008) Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol 23(4):487–496PubMedCentralPubMed
32.
go back to reference Wang W, Yang Y, Zhang W, Wu W(2014) Association of tea consumption and the risk of oral cancer: a meta-analysis. Oral Oncol Wang W, Yang Y, Zhang W, Wu W(2014) Association of tea consumption and the risk of oral cancer: a meta-analysis. Oral Oncol
33.
34.
go back to reference Dutra MF, Bristot IJ, Batassini C, Cunha NB, Vizuete AF, de Souza DF et al (2012) Effects of chronic caloric restriction on kidney and heart redox status and antioxidant enzyme activities in Wistar rats. BMB Rep 45(11):671–676PubMedCentralPubMedCrossRef Dutra MF, Bristot IJ, Batassini C, Cunha NB, Vizuete AF, de Souza DF et al (2012) Effects of chronic caloric restriction on kidney and heart redox status and antioxidant enzyme activities in Wistar rats. BMB Rep 45(11):671–676PubMedCentralPubMedCrossRef
Metadata
Title
Coffee or tea consumption and the risk of rheumatoid arthritis: a meta-analysis
Authors
Young Ho Lee
Sang-Cheol Bae
Gwan Gyu Song
Publication date
01-11-2014
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 11/2014
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-014-2631-1

Other articles of this Issue 11/2014

Clinical Rheumatology 11/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.